Literature DB >> 10693963

Altered G protein-coupling functions of RNA editing isoform and splicing variant serotonin2C receptors.

Q Wang1, P J O'Brien, C X Chen, D S Cho, J M Murray, K Nishikura.   

Abstract

Different isoforms of serotonin subtype 2C receptor (5-HT(2C)R) with altered G protein-coupling efficacy are generated by RNA editing, which converts genomically encoded adenosine residues into inosines. In combination, editing of five sites all located within the second intracellular loop region of 5-HT(2C)R mRNA changes the gene-encoded Ile, Asn, and Ile at positions 156, 158, and 160, respectively. We analyzed the G protein-coupling functions of previously unreported editing isoform receptors. An approximately 13-fold reduction in the agonist potency for G protein-coupling stimulation as well as a significantly reduced basal level activity was observed with the thalamus-specific isoform carrying Ile156, Gly158, and Val160 (5-HT(2C)R-IGV). In contrast, the agonist was four- to five-fold less potent with 5-HT(2C)R-MSV and -IDV, detected in the amygdala and choroid plexus, respectively, indicating a dominant role for the amino acid residue at position 158 in receptor functions. We also identified a splicing variant receptor with a truncated C terminus that displayed no ligand binding capacity or G protein-coupling activity. Examination of the alternatively spliced RNA encoding this truncated receptor suggests that editing of this variant RNA occurs after completion of splicing, resulting in complete editing at all five sites.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10693963     DOI: 10.1046/j.1471-4159.2000.741290.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  78 in total

1.  A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains.

Authors:  C X Chen; D S Cho; Q Wang; F Lai; K C Carter; K Nishikura
Journal:  RNA       Date:  2000-05       Impact factor: 4.942

2.  Host response to polyomavirus infection is modulated by RNA adenosine deaminase ADAR1 but not by ADAR2.

Authors:  Cyril X George; Charles E Samuel
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

3.  Serotonin 2c receptor RNA editing in major depression and suicide.

Authors:  Rebecca Lyddon; Andrew J Dwork; Mehdi Keddache; Larry J Siever; Stella Dracheva
Journal:  World J Biol Psychiatry       Date:  2012-03-09       Impact factor: 4.132

4.  Evidence that RNA editing modulates splice site selection in the 5-HT2C receptor gene.

Authors:  Rachel Flomen; Joanne Knight; Pak Sham; Robert Kerwin; Andrew Makoff
Journal:  Nucleic Acids Res       Date:  2004-04-15       Impact factor: 16.971

5.  Modulation of RNA editing by functional nucleolar sequestration of ADAR2.

Authors:  Christopher L Sansam; K Sam Wells; Ronald B Emeson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-11       Impact factor: 11.205

Review 6.  Activity regulation of adenosine deaminases acting on RNA (ADARs).

Authors:  Cesare Orlandi; Alessandro Barbon; Sergio Barlati
Journal:  Mol Neurobiol       Date:  2011-11-20       Impact factor: 5.590

7.  Deconstructing antiobesity compound action: requirement of serotonin 5-HT2B receptors for dexfenfluramine anorectic effects.

Authors:  Sophie M Banas; Stéphane Doly; Katia Boutourlinsky; Silvina L Diaz; Arnauld Belmer; Jacques Callebert; Corinne Collet; Jean-Marie Launay; Luc Maroteaux
Journal:  Neuropsychopharmacology       Date:  2010-10-06       Impact factor: 7.853

8.  Development of the 5-HT2CR-Tango System Combined with an EGFP Reporter Gene.

Authors:  Yoshihisa Watanabe; Atsushi Tsujimura; Miku Aoki; Katsutoshi Taguchi; Masaki Tanaka
Journal:  J Mol Neurosci       Date:  2015-09-15       Impact factor: 3.444

Review 9.  Adenosine deaminases acting on RNA, RNA editing, and interferon action.

Authors:  Cyril X George; Zhenji Gan; Yong Liu; Charles E Samuel
Journal:  J Interferon Cytokine Res       Date:  2010-12-23       Impact factor: 2.607

Review 10.  A-to-I RNA editing and human disease.

Authors:  Stefan Maas; Yukio Kawahara; Kristen M Tamburro; Kazuko Nishikura
Journal:  RNA Biol       Date:  2006-01-12       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.